Despite recent declines, we believe Pfizer stock is a compelling buy right now, with its current price of around $23 likely ...

Three supercharged dividend stocks have the tools and intangibles to fatten investors' pocketbooks in June, and well beyond.

Pfizer halted its oral obesity drug, danuglipron, in April 2025 due to liver injury concerns, a major pipeline setback. Find ...

Second, Pfizer's forward dividend yield stands at 7.47%. At first glance, the drugmaker's dividend payout ratio of 122.5% ...

In light of Pfizer's 75th anniversary in India, the Board of Directors has recommended a final dividend of Rs. 35/-per equity share of Rs. 10/-each (350% considering the face value of share ) and ...

The firm announced a total dividend of Rs 165 for FY25. In the corresponding quarter of the previous fiscal, Pfizer reported a net profit of Rs 179 crore. Pfizer shares ended 1.20% higher at ...

At this writing, the forward dividend yield stands at a mouthwatering 7.52%. The more you invest in Pfizer, the more income you can make. How many shares of Pfizer should you own to make $10,000 ...

With this understanding, the next table summarizes my analysis of their PEGY ... my above rating downgrade for PFE. As mouthwatering as its dividend yield is (around 7.5% as of this writing ...

Of the 22 guru strategies we follow, PFE rates highest using our Shareholder Yield Investor model based on the published strategy of Meb Faber. This strategy looks for companies returning cash to ...

PFE) for years. However, the big drugmaker's exceptionally juicy dividend these days has made its stock even more attractive. But when a dividend yield reaches ultrahigh levels, investors can feel ...